Novo Nordisk has said it will invest DKK 3.2 billion (€432 million) in a manufacturing plant in Ireland that will be used to produce its "current and future" GLP-1 agonist-based therapies for diseases ...
(a) The tabletting plant is equipped with planetary mixers, tray and fluid bed dryers, rotary compression machines and blister packing machines. (b) The capsule manufacturing plant is equipped with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results